AIM ImmunoTech Inc operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares AIM ImmunoTech Inc with three other
companies in this sector in UNITED STATES :
Pluristem Therapeutics Incorporation.
(2019
sales of $54,000.00
of which 100%
was Research and development),
Windtree Therapeutics Inc
($198,000.00
of which 100%
was Biopharmaceutical and Medical device), and
Enzon Pharmaceuticals, Inc.
($207,000.00
).
Sales Analysis.
AIM ImmunoTech Inc reported sales of $140,000.00
for the
year ending
December of 2019.
This
represents
a
sharp
decrease of 61.9%
versus 2018, when the company's sales were $367,000.00 .